Trump Administration Reaches Pricing Agreements with 9 More Drugmakers
Leerink analysts hailed the deals as a sign that President Trump “is unlikely to attack the industry in 2026.”
Trump Administration Reaches Pricing Agreements with 9 More Drugmakers Read More »
